Evidence map›Paper›PMID 36756454›Full record

ArticleRSC advances2023

RNA-DNA hybrid nano-materials for highly efficient and long lasting RNA interference effect.

Joung Sug Kim, Junghyun Park, Jang Hyeon Choi, Seungjae Kang, Nokyoung Park

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joung Sug KimDepartment of Chemistry, The Natural Science Research Institute, Myongji University 116 Myongji-Ro Yongin Gyeonggi-do Republic of Korea pospnk@mju.ac.kr.
Junghyun ParkDepartment of Chemistry, The Natural Science Research Institute, Myongji University 116 Myongji-Ro Yongin Gyeonggi-do Republic of Korea pospnk@mju.ac.kr.
Jang Hyeon ChoiDepartment of Chemistry, The Natural Science Research Institute, Myongji University 116 Myongji-Ro Yongin Gyeonggi-do Republic of Korea pospnk@mju.ac.kr.
Seungjae KangDepartment of Chemistry, The Natural Science Research Institute, Myongji University 116 Myongji-Ro Yongin Gyeonggi-do Republic of Korea pospnk@mju.ac.kr.
Nokyoung ParkDepartment of Chemistry, The Natural Science Research Institute, Myongji University 116 Myongji-Ro Yongin Gyeonggi-do Republic of Korea pospnk@mju.ac.kr.ORCID https://orcid.org/0000-0001-7764-9500
Myongji University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In attempts to effectively improve RNAi function, we herein report a new RNAi approach using X-shaped RDNA and Dgel (RNA interfering DNA hydrogel, Ri-Dgel). X-shaped RDNA is a 4 branched nanostructure which was composed of three dsDNA branches and one dsRNA branch, and the structure was made by annealing partially complementary ssDNAs and chimeric RNA-DNA oligonucleotides. Ri-Dgel was synthesized through the ligation of the X-shaped RDNAs using their palindromic sticky ends. In MDCK/GFP cells transfected with 1 μM of each format of siRNA, Ri-Dgel and X-RDNA, the intensity of GFP fluorescence was significantly reduced by 65% and 56%, respectively, while dsRNA which is a conventional siRNA format showed a relatively weak reduction intensity of 7% compared with a negative control. We also observed the decreased intensity of GFP fluorescence by approximately 59% in MDA-MB-231/GFP cells transfected with 5 nM Ri-Dgel. Furthermore, the Ri-Dgel showed persistent RNAi efficiency up to 6 days from the treatment. The use of Ri-Dgel to trigger RNAi resulted in enhanced efficacy and longer duration at lower concentration compared to traditional dsRNA implying the nanostructured DNA-RNA hybrid materials have great potential as a platform technology for RNAi-based therapy.

Identifiers

PMID36756454
PMCPMC9854246
OpenAlexW4317538578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.